[go: up one dir, main page]

GR3003363T3 - Novel 11-aryloestrane and 11-arylpregnane derivatives - Google Patents

Novel 11-aryloestrane and 11-arylpregnane derivatives

Info

Publication number
GR3003363T3
GR3003363T3 GR91402004T GR910402004T GR3003363T3 GR 3003363 T3 GR3003363 T3 GR 3003363T3 GR 91402004 T GR91402004 T GR 91402004T GR 910402004 T GR910402004 T GR 910402004T GR 3003363 T3 GR3003363 T3 GR 3003363T3
Authority
GR
Greece
Prior art keywords
group
derivatives
acyloxy
hydroxyl
carbon atoms
Prior art date
Application number
GR91402004T
Other languages
English (en)
Inventor
Marinus Bernard Groen
Jongh Hendrik Paul De
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of GR3003363T3 publication Critical patent/GR3003363T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR91402004T 1987-04-24 1991-12-17 Novel 11-aryloestrane and 11-arylpregnane derivatives GR3003363T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8700970 1987-04-24

Publications (1)

Publication Number Publication Date
GR3003363T3 true GR3003363T3 (en) 1993-02-17

Family

ID=19849909

Family Applications (1)

Application Number Title Priority Date Filing Date
GR91402004T GR3003363T3 (en) 1987-04-24 1991-12-17 Novel 11-aryloestrane and 11-arylpregnane derivatives

Country Status (17)

Country Link
US (1) US4871724A (el)
EP (1) EP0289073B1 (el)
JP (1) JP2655676B2 (el)
KR (1) KR970005318B1 (el)
CN (1) CN1019978C (el)
AT (1) ATE69820T1 (el)
AU (1) AU608831B2 (el)
CA (1) CA1297472C (el)
DE (1) DE3866410D1 (el)
DK (1) DK168294B1 (el)
ES (1) ES2045082T3 (el)
FI (1) FI88396C (el)
GR (1) GR3003363T3 (el)
IE (1) IE60783B1 (el)
NZ (1) NZ224355A (el)
PT (1) PT87322B (el)
ZA (1) ZA882643B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE172469T1 (de) * 1989-08-04 1998-11-15 Schering Ag 11 beta-aryl-gona-4,9-dien-3-one
US5407928A (en) * 1990-08-15 1995-04-18 Schering Aktiengesellschaft 11β-aryl-gona-4,9-dien-3-ones
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4434488A1 (de) 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
CN1117759C (zh) * 1999-09-02 2003-08-13 上海中西药业股份有限公司 甾体化合物,其制备方法和其药物组合物及其应用
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
BRPI0717747A2 (pt) 2006-10-24 2013-10-22 Repros Therapeutics Inc Composições e métodos de supressão da proliferação endometrial
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
MX2012010327A (es) 2010-03-22 2012-11-16 Repros Therapeutics Inc Composiciones y metodos para la administracion no toxica de antiprogestinas.
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424769A (en) * 1966-04-04 1969-01-28 Syntex Corp Process for the preparation of novel 6alpha-methyl-delta4,9(10)- diene steroids
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3461090D1 (en) * 1983-02-18 1986-12-04 Schering Ag 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
US4678282A (en) * 1985-02-19 1987-07-07 Ovonic Imaging Systems, Inc. Active display matrix addressable without crossed lines on any one substrate and method of using the same
GB8513723D0 (en) * 1985-05-31 1985-07-03 Erba Farmitalia 11-beta substituted steroids

Also Published As

Publication number Publication date
DK221888A (da) 1988-10-25
KR970005318B1 (ko) 1997-04-15
KR880012637A (ko) 1988-11-28
NZ224355A (en) 1990-03-27
PT87322B (pt) 1992-08-31
DE3866410D1 (de) 1992-01-09
US4871724A (en) 1989-10-03
FI881826A (fi) 1988-10-25
DK168294B1 (da) 1994-03-07
AU1507288A (en) 1988-10-27
ES2045082T3 (es) 1994-01-16
JP2655676B2 (ja) 1997-09-24
EP0289073B1 (en) 1991-11-27
ZA882643B (en) 1988-10-04
FI881826A0 (fi) 1988-04-19
FI88396C (fi) 1993-05-10
JPS63280097A (ja) 1988-11-17
IE60783B1 (en) 1994-08-10
IE881131L (en) 1988-10-24
DK221888D0 (da) 1988-04-22
EP0289073A1 (en) 1988-11-02
FI88396B (fi) 1993-01-29
CA1297472C (en) 1992-03-17
ATE69820T1 (de) 1991-12-15
PT87322A (pt) 1988-05-01
CN88102416A (zh) 1988-12-14
CN1019978C (zh) 1993-03-03
AU608831B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
GR3003363T3 (en) Novel 11-aryloestrane and 11-arylpregnane derivatives
GR3004783T3 (el)
IL65501A (en) 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
KR970009592B1 (en) New 11-arylsteroid compounds
AU586691B2 (en) Diamino-androstane derivatives, process for their preparation and pharmaceutical compositions containing them
EP0139535A3 (en) Compositions for combatting toxaemia
ES8305736A1 (es) Procedimiento para la preparacion de derivados de la piridazina.
FR2530248B1 (el)
PT79158A (fr) Derives de nitrosourees leur procede de preparation et compositions pharmaceutiques les contenant
JPS6463517A (en) Antianxiety composition
FR2593810B1 (fr) Derives de la quinoleine, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant
JPS5414998A (en) Prostaglandin i2 analog and its preparation